Pharmafile Logo

Clinical trials explained: Why branding matters…

November 7, 2023 |  

With nearly a decade’s experience supporting clinical trials, find out why we think humanising trials through design is so important.

Let us ask you a question.

What percentage of clinical trials do you think meet their recruitment targets on time?

Half? Maybe less?

Well, in fact it’s a lot less because that figure is typically around 15%. Which not only increases costs, but often delays results too. We know that joining a clinical study can be daunting for people, which is why it’s vital that patient perspective plays a part in helping to formulate the trial.

But trial branding can also play an important role.

Branding your trial can help to:

  • Attract your target patient population and enable to you to connect with them at a deeper level
  • Reduce possible participation-related anxiety by promoting credibility
  • Build patient trust through the use of a consistent look and feel that they can follow throughout their trial experience
  • Help to promote a feeling for patients that they are a part of something meaningful

This approach also supports HCPs with effective study delivery – all the way from recruitment through to retention, with patients feeling overall more engaged throughout.

And it is because of this that a strong partnership with a healthcare communications agency is essential; not only will it help to determine the effectiveness of the study branding, but also the subsequent creation of patient and HCP support materials.

With nearly a decade of experience supporting clinical trials, Cuttsy+Cuttsy recognise the importance of taking the time and care to uncover the heart and soul of a study. So, while it can be tempting to rush through the branding stage and jump straight to the delivery of finished materials such as recruitment posters and study aids, our experience shows that systematically conducting a variety of research provides an understanding of patients’ rational and emotional concerns. This enables us to help develop a meaningful, patient-centric branding model that truly resonates. We use this to steer our thinking — from a trial’s purpose, through contextual considerations about what patients need and how they might benefit, to its corresponding ‘personality’:

Our Branding Heart

- PMLiVE

Whatever stage you are at with your clinical study, it is always useful to apply the branding model. Trials that are developed with true insights can improve a participant’s study journey, encourage recruitment and retention, and hopefully provide better patient outcomes. Ultimately, this will always be why we do what we do.

If you would like to work with a healthcare communications agency that will put patients at the heart of your next clinical trial, let’s talk.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...